Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 115 filers reported holding Y-MABS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,479,790 | -21.6% | 2,473,356 | -2.3% | 0.00% | – |
Q2 2023 | $17,190,780 | +45.3% | 2,531,779 | +7.2% | 0.00% | – |
Q1 2023 | $11,829,077 | -6.0% | 2,361,093 | -8.4% | 0.00% | – |
Q4 2022 | $12,584,427 | -69.9% | 2,578,776 | -11.0% | 0.00% | -100.0% |
Q3 2022 | $41,780,000 | -7.2% | 2,897,394 | -2.6% | 0.00% | 0.0% |
Q2 2022 | $45,031,000 | +28.7% | 2,976,221 | +1.1% | 0.00% | 0.0% |
Q1 2022 | $34,986,000 | -22.0% | 2,945,094 | +6.4% | 0.00% | 0.0% |
Q4 2021 | $44,859,000 | -42.6% | 2,767,360 | +1.1% | 0.00% | -50.0% |
Q3 2021 | $78,110,000 | -14.5% | 2,736,860 | +1.2% | 0.00% | -33.3% |
Q2 2021 | $91,385,000 | +19.7% | 2,703,691 | +7.1% | 0.00% | +50.0% |
Q1 2021 | $76,350,000 | -36.2% | 2,524,776 | +4.4% | 0.00% | -50.0% |
Q4 2020 | $119,744,000 | +33.0% | 2,418,580 | +3.1% | 0.00% | +33.3% |
Q3 2020 | $90,053,000 | -9.8% | 2,345,757 | +1.5% | 0.00% | -25.0% |
Q2 2020 | $99,869,000 | +93.2% | 2,311,792 | +16.8% | 0.00% | +33.3% |
Q1 2020 | $51,680,000 | -17.9% | 1,980,069 | -1.6% | 0.00% | +50.0% |
Q4 2019 | $62,910,000 | +82.3% | 2,013,091 | +52.0% | 0.00% | +100.0% |
Q3 2019 | $34,518,000 | +30.8% | 1,324,567 | +14.8% | 0.00% | 0.0% |
Q2 2019 | $26,387,000 | +172.7% | 1,153,831 | +212.6% | 0.00% | – |
Q1 2019 | $9,676,000 | +39.2% | 369,159 | +8.0% | 0.00% | – |
Q4 2018 | $6,952,000 | +1646.7% | 341,831 | +2178.9% | 0.00% | – |
Q3 2018 | $398,000 | – | 15,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 191,176 | $1,041,909 | 4.24% |
Sofinnova Investments, Inc. | 2,194,278 | $11,958,815 | 0.75% |
DENALI ADVISORS LLC | 85,900 | $468,155 | 0.16% |
Polar Capital Holdings Plc | 2,103,298 | $11,462,974 | 0.08% |
Soleus Capital Management, L.P. | 157,182 | $856,642 | 0.08% |
GSA CAPITAL PARTNERS LLP | 137,299 | $748 | 0.06% |
Caligan Partners LP | 23,321 | $127,099 | 0.06% |
Corton Capital Inc. | 12,244 | $66,730 | 0.03% |
RICE HALL JAMES & ASSOCIATES, LLC | 91,249 | $497,307 | 0.03% |
CIM INVESTMENT MANAGEMENT INC | 15,313 | $83,456 | 0.03% |